ImmunoGen Inc (NASDAQ:IMGN)

5.25
Delayed Data
As of 3:59pm ET
 -0.06 / -1.13%
Today’s Change
3.10
Today|||52-Week Range
7.77
-29.25%
Year-to-Date
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates
Aug 01 / Zacks.com - Paid Partner Content
ImmunoGen (IMGN) Reports Q2 Loss, Lags Revenue Estimates
Jul 29 / Zacks.com - Paid Partner Content
ImmunoGen (IMGN) Q2 2022 Earnings Call Transcript
Jul 30 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close5.31
Today’s open5.29
Day’s range5.20 - 5.51
Volume258,567
Average volume (3 months)3,504,830
Market cap$1.2B
Data as of 3:59pm ET, 08/11/2022

Growth & Valuation

Earnings growth (last year)-168.28%
Earnings growth (this year)-28.41%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-47.20%
P/E ratioNM
Price/Sales21.90
Price/Book3.69

Competitors

 Today’s
change
Today’s
% change
CDMOAvid Bioservices Inc-0.26-1.35%
DCPHDeciphera Pharmaceut...-1.44-8.37%
AUPHAurinia Pharmaceutic...-0.34-4.00%
MRUSMerus NV-1.33-5.05%
Data as of 4:00pm ET, 08/11/2022

Financials

Next reporting dateOctober 28, 2022
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$69.9M
Annual profit (last year)-$139.3M
Net profit margin-199.41%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Waltham, Massachusetts

Forecasts